Concurrent Chemoradiotherapy versus Intensity-modulated Radiotherapy Alone for Elderly Nasopharyngeal Carcinoma Patients with Pre-treatment Epstein-Barr Virus DNA: A Cohort Study in an Endemic Area with Long-term Follow-up

Conclusions: In the era of IMRT, CCRT retained survival benefits at high EBV DNA levels but not at low EBV DNA levels for elderly NPC patients. Randomized clinical trials are needed to confirm our findings.

Source: Journal of Cancer - December 14, 2018 Category: Cancer & Oncology Authors: Qin Yang, Ting-Ting Zhao, Meng-Yun Qiang, Liang Hu, Xing Lv, Yan-Fang Ye, Liang-Ru Ke, Ya-Hui Yu, Wen-Ze Qiu, Guo-Ying Liu, Xin-Jun Huang, Wang-Zhong Li, Shu-Hui Lv, Yao Sun, Lu-Yao Zhang, Fei Pei, Xiang Guo, Yan-Qun Xiang, Chao-Nan Qian, Bi-Jun Huang, We Tags: Research Paper Source Type: research